Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Validating the Effect of Ondansetron and Mirtazapine in Treating Hyperemesis Gravidarum
2018-002285-39Phase 2Terminated
- Sponsor
- Department of Gynaecology and Obstetrics, Nordsjællands Hospital
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in hyperemesis gravidarum (HG) comparing Mirtazapine, Ondansetron and Placebo (3 arms). Primary endpoint: Co-primary endpoints. Started Sep 2018; status: terminated.
02
Drugs
mirtazapineondansetron
03
Conditions
hyperemesis gravidarum (HG)
Beyond the preview
Go deeper on 2018-002285-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002285-39.